Principal Scientist - Immunology Clinical Development

Scorpion Therapeutics; North Wales (Montgomery County); On-site; USD 180,000 - 260,000; Full time

Job summary

Scorpion Therapeutics, based in the United States, seeks a clinical development leader in Immunology to guide investigational compounds through the full clinical lifecycle, from indication selection to regulatory filing and publication.

The role requires extensive experience in Phase 2/3 trials, collaboration across commercialization, regulatory, statistics, and manufacturing, and a proven track record in industry drug development. Strong leadership and communication are essential.

Qualifications

• Phase 2/3 clinical trial design and execution in Immunology.
• 3+ years of clinical medicine experience.
• 5+ years in industry drug development.
• Demonstrated scientific scholarship.
• Strong interpersonal skills and cross-functional collaboration.

Responsibilities

• Strategically plan and direct clinical research activities for investigational compounds in Immunology throughout the full development cycle.
• Evaluate pre-clinical and translational work to inform early clinical plans and INDs.
• Support business development assessments to grow the Immunology pipeline.
• Develop clinical development strategies and plan trials (design and operational plans).
• Monitor and manage ongoing and new clinical trials.
• Summarize clinical findings to support safety/efficacy decisions and regulatory submissions.
• Collaborate with cross-functional teams to manage clinical development projects.
• Supervise Clinical Scientists and foster external collaborations.

Skills

Clinical Decision Making

Clinical Development

Clinical Documentation

Clinical Judgment

Data Analysis

Dermatology

Drug Development

Immunology

Education

MD/DO/MD-PhD

Job description

Scorpion Therapeutics, based in the United States, seeks a clinical development leader in Immunology to guide investigational compounds through the full clinical lifecycle, from indication selection to regulatory filing and publication.

The role requires extensive experience in Phase 2/3 trials, collaboration across commercialization, regulatory, statistics, and manufacturing, and a proven track record in industry drug development. Strong leadership and communication are essential.